» Articles » PMID: 30091306

Association of Central Serous Chorioretinopathy with Psychosocial Factors is Dependent on Its Phase and Subtype

Overview
Specialty Ophthalmology
Date 2018 Aug 10
PMID 30091306
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To analyze the psychosocial factors associated with central serous chorioretinopathy (CSC) according to its phases and subtypes and to correlate the factors with the extent of choroidal hyperpermeability.

Methods: Age- and sex-matched CSC patients and controls (n = 37 in each group) were enrolled, and their psychosocial factors were compared. CSC was divided into two phases (active and inactive), and active CSC was further divided into two subtypes (acute and chronic). The correlations between the size of the hyperpermeable choroidal lesion identified on indocyanine green angiography and psychosocial factors were examined.

Results: Active CSC patients experienced more stressful events (p = 0.030), were more depressive (p = 0.037), and felt less emotional (p = 0.014) and informational (p = 0.014) support than the matched controls, whereas inactive CSC patients were comparable to the matched controls in all psychosocial factors. Among the active CSC patients, acute patients were more depressive (p = 0.029), while chronic patients experienced more stressful events (p = 0.024) than their matched controls. The size of the hyperpermeable choroidal lesion was correlated with the severity of depression in acute patients.

Conclusions: Association of CSC with psychosocial factors was dependent on the phase and subtype of CSC. Psychosocial factors were associated with CSC in the active phase, and severity of depression was correlated with the size of the choroidal pathology in acute active CSC. Further prospective studies to investigate if psychosocial factors can trigger CSC are warranted.

Citing Articles

[Stress and other risk factors in central serous chorioretinopathy-A myth?].

Hufnagel H, Lahmann C, Pauleikhoff L, Lange C Ophthalmologie. 2025; 122(3):162-169.

PMID: 39820495 DOI: 10.1007/s00347-024-02179-2.


Association of central serous chorioretinopathy with type of personality, anxiety, and depression.

Karmakar S Indian J Ophthalmol. 2024; 72(11):1680-1682.

PMID: 39462936 PMC: 11668208. DOI: 10.4103/IJO.IJO_491_24.


Concerns and observations on "Association of central serous chorioretinopathy with type of personality, anxiety and depression".

Brar M, Brar A Indian J Ophthalmol. 2024; 72(Suppl 4):S715-S716.

PMID: 38953135 PMC: 11338434. DOI: 10.4103/IJO.IJO_298_24.


Psychometric assessment of patients with central serous chorioretinopathy and correlation with disease stage and progression: a case control study.

Hufnagel H, Lahmann C, Agostini H, Lange C, Pauleikhoff L BMC Ophthalmol. 2024; 24(1):92.

PMID: 38424605 PMC: 10902987. DOI: 10.1186/s12886-024-03356-2.


Association of Central serous chorioretinopathy with type of personality, anxiety and depression.

Mukherji S, Karmakar S, Dasgupta S Indian J Ophthalmol. 2023; 72(Suppl 1):S60-S65.

PMID: 38131544 PMC: 10833166. DOI: 10.4103/IJO.IJO_1180_23.


References
1.
Piskunowicz M, Jaracz M, Lesiewska H, Malukiewicz G, Brozek-Pestka M, Borkowska A . Temperament profile in patients with central serous chorioretinopathy: a case-control study. Eur J Ophthalmol. 2013; 24(3):392-5. DOI: 10.5301/ejo.5000377. View

2.
Yannuzzi L . Type-A behavior and central serous chorioretinopathy. Retina. 1987; 7(2):111-31. DOI: 10.1097/00006982-198700720-00009. View

3.
Tsai D, Chen S, Huang C, Chou P, Chung C, Huang P . Epidemiology of idiopathic central serous chorioretinopathy in Taiwan, 2001-2006: a population-based study. PLoS One. 2013; 8(6):e66858. PMC: 3691239. DOI: 10.1371/journal.pone.0066858. View

4.
Spaide R, Campeas L, Haas A, Yannuzzi L, Fisher Y, Guyer D . Central serous chorioretinopathy in younger and older adults. Ophthalmology. 1996; 103(12):2070-9; discussion 2079-80. DOI: 10.1016/s0161-6420(96)30386-2. View

5.
Bousquet E, Beydoun T, Rothschild P, Bergin C, Zhao M, Batista R . SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY: A RANDOMIZED CONTROLLED CROSSOVER STUDY. Retina. 2015; 35(12):2505-15. PMC: 4697359. DOI: 10.1097/IAE.0000000000000614. View